New perspectives and solutions in the treatment of schizophrenia

Schizophrenia is a disorder in which the patient experiences loss of a part or the whole of the perception of… reality, and can result in delusions, paranoid ideation, delusions or bizarre thoughts (psychotic symptoms).
The disease has been described since antiquity, has a long history and it is estimated that it affects 1% of the population.
The treatment of schizophrenia is multifactorial. Despite the fact that there are a lot of available antipsychotic medications, their effectiveness may be limited due to occurrence of adverse events or difficulty in adherence to the dose.
Recent years have seen an intense and promising research activity in the field of creation of newer effective therapies, but also with the remission of symptoms with a focus on ensuring a good quality of life for patients with fewer side effects and a lower incidence of doses.
The lawsuits long acting can help patients to continue tirelessly their treatment, minimizing the time engaging with taking the drug. While many treatments require taking pills one or more times per day, the later treatments, long-acting, administered infrequently, usually once a month, or every 3 months, reducing the preoccupation with the drug in everyday life, offering a more normal life for both patients and their families. A key advantage of the pipeline long-acting is the freedom of patients they can focus on the daily functions of life, to socialise and to reduce the risk of a relapse and progression of the disease.
Advantages of treatment options
Daily treatment
Daily download
Simple and convenient (does not require the presence of a health professional for administration)
Provides a sense of “control”
Looks familiar. Treatment long-acting
Freedom from the usually more complicated dosing regimens, and regular intake of medicines
Meeting with a health care professional for the administration
Confidence that he has correctly complied with the treatment for the family
Can offer improvement in adherence to treatment
Less risk of relapse
The non-compliance is immediately perceived
A few words about the treatments long-acting
The treatments long-acting, such as, for example, the palmitate paliperidone, increase the time between doses and have been shown to be beneficial for people with schizophrenia, which may forget or neglect to take daily antipsychotic treatment. This offers patients greater independence and the opportunity to focus more on daily operations and less on dealing with taking medication.
Non-compliance with medication is a major factor of relapse in patients with schizophrenia, and even small vacation αντιψυχωσικής therapy can lead to patient deterioration. The treatments long-acting relieve the patient from the burden of daily treatment and so reduce the chance of recurrence and progression of the disease.
The treatments long-acting help health professionals and their carers to feel more quiet, as they know that the person with schizophrenia who take care of benefit from the continuous taking of medication between the fixed doses. Also given the opportunity for frequent contact between the patient and physician, which helps in the building of the therapeutic relationship and alliance.
Studies show that many patients treated long-acting preferred over receiving daily treatment, and for this reason it is important to offered another type of treatment, in addition to medications taken by mouth. To achieve the best possible results and to be sustainable, the treatments, long-acting, may be offered early in the treatment plan, rather than be given as a last resort.
Source